FDA NDC Directory · JSON-LD · Markdown

Neostigmine Methylsulfate

NDC 70069-805 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerSomerset Therapeutics, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA213074
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsNEOSTIGMINE METHYLSULFATE (.5 mg/mL)
Marketing started20220110
Package count1

External sources

Source: openFDA. Public-domain (CC0).